News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Flugen, Inc. Secures Exclusive Rights to Novel Vaccine-Delivery Technology


3/24/2009 11:47:46 AM

MADISON, Wis.--(BUSINESS WIRE)--FluGen Inc., an emerging leader in the development, production and delivery of influenza vaccines and related products, today announced it has secured exclusive rights to a novel, patent-protected vaccine-delivery technology being commercialized by Madison, Wis.-based Ratio Inc. Terms of the license agreement were not disclosed.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES